Cargando…
Anti-Diabetic Agents and Heart Failure ― Response to the CARMELINA Study ―
According to cardiovascular outcome trials, some anti-diabetic drugs can improve cardiovascular outcomes in patients with type 2 diabetes. Sodium glucose cotransporter 2 inhibitors (empagliflozin, canagliflozin, and dapagliflozin) have a strong preventive effect on both hospitalization for heart fai...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Circulation Society
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925121/ https://www.ncbi.nlm.nih.gov/pubmed/33693068 http://dx.doi.org/10.1253/circrep.CR-18-0011 |